Working hours24*7 AvailableCall us+91 9967979080
Lurbinectedin

Lurbinectedin

Generic Name/API:Lurbinectedin
Packaging:ZEPZELCA (lurbinectedin) for injection is supplied as a sterile, preservative-free, white to off white lyophilized powder in a single-dose clear glass vial. Each carton contains 4 mg in one single-dose vial.
Storage:Store refrigerated at 2° to 8°C (36° to 46°F)
Dosage:For dosage information, please check the General Information section.
Strength:For injection: 4 mg of lurbinectedin as a sterile, preservative-free, white to off-white lyophilized powder in a single-dose vial for reconstitution prior to intravenous infusion.
Indication:ZEPZELCA® (lurbinectedin) is an alkylating agent approved for the treatment of adults with metastatic small cell lung cancer (SCLC) whose disease has progressed following platinum-based chemotherapy.

ZEPZELCA® (lurbinectedin) is a prescription medicine used to treat adults with a kind of lung cancer called small cell lung cancer (SCLC) that has progressed and metastasized even after receiving platinum based chemotherapy. It is a unique DNA-binding alkylating agent that disrupts transcription and DNA repair pathways, leading to cancer cell death. 

STRENGTH: 

For injection: 4 mg of lurbinectedin as a sterile, preservative-free, white to off-white lyophilized powder in a single-dose vial for reconstitution prior to intravenous infusion. 

DOSAGE:  

Recommended Dosage

The recommended dosage of lurbinectedin is 3.2 mg/m2 by intravenous infusion over 60 minutes every 21 days until disease progression or unacceptable toxicity. Initiate treatment with lurbinectedin only if absolute neutrophil count (ANC) is at least 1,500 cells/mm3 and platelet count is at least 100,000/mm3

Dose reduction  Total dose
First  2.6 mg/m2 every 21 days 
Second  2 mg/m2 every 21 days 

Dosage modifications for adverse reactions 

Permanently discontinue ZEPZELCA in patients who are unable to tolerate 2 mg/m2 or require a dose delay greater than two weeks.  

Adverse reactions  Severity  Dosage modifications 
Neutropenia  Grade 4 or any grade febrile neutropenia 
  • Withhold ZEPZELCA until Grade ≤ 1
  • Resume ZEPZELCA at a reduced dose 
Thrombocytopenia Grade 3 with bleeding or grade 4
  • Withhold ZEPZELCA until platelet ≥ 100,000/mm3 
  • Resume ZEPZELCA at reduced dose 
Hepatotoxicity Grade 2
  • Withhold ZEPZELCA until Grade ≤ 1
  • Resume ZEPZELCA at same dose 
Grade ≥ 3
  • Withhold ZEPZELCA until Grade ≤ 1
  • Resume ZEPZELCA at reduced dose 

SIDE EFFECTS: 

Following are the clinically significant adverse reactions:

  • Myelosuppression
  • Hepatotoxicity 

STORAGE: 

  • Store refrigerated at 2° to 8°C (36° to 46°F). 
  • Lurbinectedin is a hazardous drug. It is advised to follow applicable special handling and disposal procedures. 

The following adverse reactions and their severity as mentioned were observed in patients with advanced solid tumours under treatment with lurbinectedin: 

  1. Myelosuppression: Lurbinectedin can cause myelosuppression. In clinical studies, Grade 3 or 4 neutropenia occurred in 41% (median onset: 15 days; duration: 7 days), febrile neutropenia in 7%, and sepsis in 2% (1% fatal, none in SCLC). Grade 3 or 4 thrombocytopenia and anemia occurred in 10% and 17% of patients, respectively. Administer lurbinectedin only to patients with baseline neutrophil count of at least 1,500 cells/mm3 and platelet count of at least 100,000/mm3. Monitor blood counts with neutrophil and platelet count before each administration. For neutrophil count less than 500 cells/mm3 or any value less than lower limit of normal, the use of G-CSF is recommended.
  2. Hepatotoxicity:  In clinical studies, serious liver enzyme elevations (Grade ≥3 ALT/AST) occurred in up to 6% of patients, usually starting around day 8 and lasting about a week. It is advised to monitor liver function tests, prior to initiating treatment, periodically during treatment, and as clinically indicated.
  3. Embryo-fetal toxicity: Based on animal data and its mechanism of action lurbinectedin can cause fetal harm when administered to a pregnant woman. Embryolethality was observed in animal studies with rats. 

For all above mentioned adverse reactions, withhold, reduce the dose, or permanently discontinue lurbinectedin based on severity. 

Process to Import Medicine

FAQ

  • What is lurbinectedin ?
  • What is lurbinectedin used for?
  • What are the common side effects of lurbinectedin use?
  • Can lurbinectedin be used in specific populations i.e. for pregnant, breastfeeding , pediatric and geriatric use?
  • What is the cost of lurbinectedin (zepzelca) in India?
  • How to buy lurbinectedin (zepzelca) injection online in India?
  • What are the key criteria for selecting a supplier?
What is lurbinectedin ?

  Lurbinectedin binds to DNA, disrupting transcription and repair pathways, inhibiting monocyte activity, reducing tumor-associated macrophages, and ultimately causing cancer cell death.

What is lurbinectedin used for?

 ZEPZELCA® (lurbinectedin) is a prescription medicine used to treat adults with a kind of lung cancer called small cell lung cancer (SCLC) that has progressed and metastasized even after receiving platinum based chemotherapy.

What are the common side effects of lurbinectedin use?

The primary side effects of lurbinectedin include hepatotoxicity, myelosuppression and embryo-fetal toxicity.

Can lurbinectedin be used in specific populations i.e. for pregnant, breastfeeding , pediatric and geriatric use?

 Based on animal data and its mechanism of action, lurbinectedin can cause fetal harm when administered to a pregnant woman. There are no available data to inform the risk of use in pregnant women. Animal studies show a chance of embryolethality.

What is the cost of lurbinectedin (zepzelca) in India?

The cost of lurbinectedin (zepzelca) in India varies as it must be imported, since it’s not approved for local sale. Factors like supplier availability, import fees, and currency fluctuations affect final pricing. For up-to-date cost details, contact 24/7QualityMeds at +91 9967979080.

How to buy lurbinectedin (zepzelca) injection online in India?

To buy Zepzelca (Lurbinectedin) injection in India at a genuine price, contact 24/7QualityMeds. We help with prescription verification, import documentation, sourcing from certified suppliers, and ensure reliable delivery to your location.

What are the key criteria for selecting a supplier?

While selecting a supplier, we essentially ensure that the supplier holds a valid Good Distribution Practice (GDP) certificate and possesses a valid operating license. These credentials confirm that the suppliers adherence to International standards for the proper distribution of medicinal product

"I am very happy with experience of delivery medicine! From start to finish, everything was smooth, professional, and exceeded my expectations. The coordinator was incredibly responsive and friendly, and the product itself best in condition exactly as described. Delivery was fast, packaging was secure, and I felt truly valued as a customer. I’ll be coming back and recommending this to friends and family. Once again Thanks for delivering medicine with in 24 hours which help my wife to start treatment on time. "

- Mr. Sanjay More

"I’ve been using this medicine delivery service for a few months now, and I couldn’t be happier. The ordering process is simple and user-friendly, and the delivery is always prompt and reliable. I especially appreciate the timely updates, which help me stay on track with my prescriptions. The coordinator team is responsive and genuinely helpful, always ready to answer questions or resolve any issues. The packaging is secure, and the medicines always arrive in perfect condition. This service has made managing my health so much easier and stress-free. Highly recommended for anyone looking for convenience, reliability, and great customer care! "

- Mr. Nilesh Patankar

"I’m really impressed with the level of service. From placing the order to receiving the medicines, everything is smooth and hassle-free. The coordinator even called several times for updates my package. It’s rare to find such thoughtful service these days!"

- Mr. Mohit Vishwakarma

About us

We're a dedicated team of medicine access experts, doctors and pharmacists. We come from all over the world. And we've lost family and friends who could not get the medicine they needed because they lived in the wrong country.

Our mission is to get everyone the right treatment at the right time. Wherever you live. Because you should not suffer or die if a treatment that could help you exists somewhere.

Learn more ›

If you have any questions or need help, we're a phone call away. Our team is available from Monday to Friday between 9 a.m and 6 p.m CET

We usually respond to emails within 24 working hours

Worldwide Delivery

Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, Antigua & Barbuda, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia & Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, British Virgin Islands, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling) Islands, Colombia, Comoros, Congo - Brazzaville, Congo - Kinshasa, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czechia, Côte d'Ivoire, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guernsey, Guinea, Guinea-Bissau, Guyana, Haiti, Heard & McDonald Islands, Honduras, Hong Kong SAR China, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Isle of Man, Israel, Italy, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macao SAR China, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar (Burma), Namibia, Nauru, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, North Korea, North Macedonia, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Palestinian Territories, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn Islands, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Réunion, Saint Barthélemy, Samoa, San Marino, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Georgia & South Sandwich Islands, South Korea, Spain, Sri Lanka, St. Helena, St. Kitts & Nevis, St. Lucia, St. Martin, St. Pierre & Miquelon, St. Vincent & Grenadines, Sudan, Suriname, Svalbard & Jan Mayen, Sweden, Switzerland, Syria, São Tomé & Príncipe, Taiwan, Province of China, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tokelau, Tonga, Trinidad & Tobago, Tunisia, Turkey, Turkmenistan, Turks & Caicos Islands, Tuvalu, U.S. Outlying Islands, U.S. Virgin Islands, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Vatican City, Venezuela, Vietnam, Wallis & Futuna, Western Sahara, Yemen, Zambia, Zimbabwe, Åland Islands

Disclaimer

All trademarks, logos, brand names, and product names appearing on this website are the property of their respective owners. 247qualitymeds.com does not claim any ownership or affiliation with these trademarks or brands. They are used solely for informational and reference purposes to help users identify products and understand their intended use. The presence of any trademark or brand name on this website does not imply endorsement, sponsorship, or association with 247qualitymeds.com in any form.